2022-10-13 Purchase |
2022-10-17 4:42 pm |
Axcella Health Inc. |
AXLA |
Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner |
10,383,760 |
$1.64 |
$17,029,366 |
8,850,296 (Indirect) |
View |
2022-05-27 Purchase |
2022-06-01 7:00 pm |
Evelo Biosciences Inc. |
EVLO |
Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner |
27,397,259 |
$1.46 |
$39,999,998 |
27,233,921 (Indirect) |
View |
2022-03-16 Purchase |
2022-03-18 08:30 am |
Axcella Health Inc. |
AXLA |
Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner |
6,319,371 |
$1.91 |
$12,069,999 |
8,262,725 (Indirect) |
View |
2021-03-19 Purchase |
2021-03-23 5:30 pm |
Rubius Therapeutics Inc. |
RUBY |
Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner |
210,000 |
$29 |
$6,090,000 |
17,253,519 (Indirect) |
View |
2021-02-08 Purchase |
2021-02-10 5:30 pm |
Kaleido Biosciences Inc. |
KLDO |
Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. AFEYAN NOUBAR 10% Owner |
215,000 |
$11.5 |
$2,472,500 |
14,907,627 (Indirect) |
View |
2021-02-02 Purchase |
2021-02-04 5:56 pm |
Evelo Biosciences Inc. |
EVLO |
Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. AFEYAN NOUBAR 10% Owner |
130,000 |
$15 |
$1,950,000 |
17,660,752 (Indirect) |
View |
2020-10-27 Purchase |
2020-10-29 4:58 pm |
Foghorn Therapeutics Inc. |
FHTX |
Flagship Ventures Fund V General Partner LLC Flagship Ventures Opportunities Fund I General Partner LLC Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner |
150,000 |
$16 |
$2,400,000 |
1,851,801 (Indirect) |
View |
2020-06-29 Purchase |
2020-07-01 5:24 pm |
Evelo Biosciences Inc. |
EVLO |
Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner |
4,666,666 |
$3.75 |
$17,499,998 |
17,614,323 (Indirect) |
View |
2020-06-04 Purchase |
2020-06-08 4:46 pm |
Kaleido Biosciences Inc. |
KLDO |
Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner |
2,000,000 |
$7.5 |
$15,000,000 |
14,835,960 (Indirect) |
View |
2020-05-18 Purchase |
2020-05-20 5:15 pm |
Axcella Health Inc. |
AXLA |
Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner |
3,800,000 |
$4.75 |
$18,050,000 |
6,682,882 (Indirect) |
View |